Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation
Lulu Cao, Jinhai Deng, Wei Chen, Minwei He, Ning Zhao, He Huang, Lu Ling, Qi Li, Xiaoxin Zhu, Lu Wang
Lulu Cao, Jinhai Deng, Wei Chen, Minwei He, Ning Zhao, He Huang, Lu Ling, Qi Li, Xiaoxin Zhu, Lu Wang
View: Text | PDF
Research Article Autoimmunity

CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation

  • Text
  • PDF
Abstract

C1q/TNF-related protein 4 (CTRP4) is generally thought to be released extracellularly and plays a critical role in energy metabolism and protecting against sepsis. However, its physiological functions in autoimmune diseases have not been thoroughly explored. In this study, we demonstrate that Th17 cell–associated experimental autoimmune encephalomyelitis was greatly exacerbated in Ctrp4–/– mice compared with WT mice due to increased Th17 cell infiltration. The absence of Ctrp4 promoted the differentiation of naive CD4+ T cells into Th17 cells in vitro. Mechanistically, CTRP4 interfered with the interaction between IL-6 and the IL-6 receptor (IL-6R) by directly competing to bind with IL-6R, leading to suppression of IL-6–induced activation of the STAT3 pathway. Furthermore, the administration of recombinant CTRP4 protein ameliorated disease symptoms. In conclusion, our results indicate that CTRP4, as an endogenous regulator of the IL-6 receptor–signaling pathway, may be a potential therapeutic intervention for Th17-driven autoimmune diseases.

Authors

Lulu Cao, Jinhai Deng, Wei Chen, Minwei He, Ning Zhao, He Huang, Lu Ling, Qi Li, Xiaoxin Zhu, Lu Wang

×

Figure 2

Ctrp4 deficiency exacerbates EAE progression with increased infiltration of CD4+ T cells in the CNS.

Options: View larger image (or click on image) Download as PowerPoint

Ctrp4 deficiency exacerbates EAE progression with increased infiltratio...
(A) After immunization with MOG peptide, the progression of disease was monitored. Clinical EAE scores and body weights of Ctrp4–/–(n = 10) or WT (n = 10) mice following disease induction are shown. Statistical significance was determined using 2-way repeated measures ANOVA. (B) Spinal cord sections were stained with H&E or Luxol fast blue (LFB). Histological images are representative of 3 mice in each group. Scale bars: 200 μm. (C and D) Single cells were isolated from the CNS on day 18 after EAE induction and stained with the indicated cell type–specific markers. Summary bar graph shows absolute numbers of CNS-infiltrating immune cells in control and Ctrp4–/– mice (C). Representative flow cytometry plots of macrophage (CD45hiF4/80+) and microglia (CD45loF4/80+) infiltrated in CNS are shown (D). (E and F) Representative flow cytometry plots showed percentages of IFN-γ+CD4+, IL-17A+CD4+, and IFN-γ+IL-17A+CD4+ in CNS of WT and Ctrp4–/– mice (n = 5 mice per group) on day 18 after EAE induction. Quantified percentages (E) and absolute cell numbers (F) are shown. (G and H) Recall response of antigen-specific T cells from the dLNs of WT and Ctrp4–/– mice on day 9 after EAE induction. CD4+ T cells were expanded with irradiated autologous-presenting cells plus 10 μg/mL (G) or the indicated concentration (H) of MOG peptide for 72 hours and subjected to cell-proliferation assay to determine T cell recall response based on BrdU assay (G) and ELISA assay (H) to quantitate the production of IL-17A and IFN-γ. (I) Flow cytometric analysis of CFSE-labeled CD4+ T cells and quantification of intracellular cytokine staining at day 5 after in vitro coculturing with irradiated autologous-presenting cells plus 10 μg/mL MOG peptide. The percentages of IL-17+ and IFN-γ+ cells were gated on CSFEloCD4+ T cells, and data are presented as representative flow plots. Data are represented as mean ± SEM and are from 1 of 3 independent experiments with similar results. (C–H) Statistical significance was determined using 2-tailed, unpaired Student’s t test or Mann-Whitney U test as appropriate after assessing for distribution. *P < 0.05; **P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts